Clinical trial
Evaluation of the Efficacy of Sleepinnov© (Spiri+) Continuous Positive Airway Pressure Device
NCT04141176 is registered in ClinicalTrials.gov with Sleepinnov Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Sleepinnov© (Spiri+) Continuous Positive Airway Pressure Device
- Lead sponsor
- Sleepinnov Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 16, 2019
- Completion date
- June 23, 2020
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea syndrome